
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.560 | 3.560 | 0.000 |
Stocks | 96.440 | 96.440 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.745 | 20.887 |
Price to Book | 5.293 | 4.029 |
Price to Sales | 2.573 | 2.792 |
Price to Cash Flow | 13.189 | 14.528 |
Dividend Yield | 1.548 | 1.543 |
5 Years Earnings Growth | 11.187 | 10.944 |
Name | Net % | Category Average |
---|---|---|
Communication Services | 24.520 | 8.883 |
Healthcare | 22.860 | 12.490 |
Technology | 22.500 | 29.231 |
Financial Services | 12.470 | 14.848 |
Utilities | 6.430 | 2.611 |
Consumer Cyclical | 3.820 | 10.698 |
Consumer Defensive | 3.010 | 5.670 |
Energy | 2.900 | 3.531 |
Industrials | 1.480 | 8.701 |
Number of long holdings: 32
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Meta Platforms | US30303M1027 | 7.97 | 543.57 | -0.50% | |
Eli Lilly | US5324571083 | 7.05 | 732.41 | +1.60% | |
Applovin | US03831W1080 | 6.52 | 249.95 | -5.26% | |
Microsoft | US5949181045 | 6.08 | 388.45 | +1.86% | |
AT&T | US00206R1023 | 5.11 | 26.79 | +1.52% | |
NVIDIA | US67066G1040 | 4.65 | 110.93 | +3.12% | |
Netflix | US64110L1061 | 3.88 | 918.29 | -0.31% | |
Novo Nordisk ADR | US6701002056 | 3.69 | 64.73 | +5.75% | |
Amazon.com | US0231351067 | 3.68 | 184.87 | +2.01% | |
Visa A | US92826C8394 | 3.43 | 333.40 | +2.71% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BH481053 | 3.65B | 26.12 | 13.15 | - | ||
IE00BH480X12 | 3.65B | 26.92 | 13.85 | - | ||
IE00BYW5Q809 | 2.23B | 12.84 | 4.83 | - | ||
IE0006TUI4G7 | 182.73M | 2.73 | -1.47 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review